000 | 01187 a2200361 4500 | ||
---|---|---|---|
005 | 20250512013252.0 | ||
264 | 0 | _c19891215 | |
008 | 198912s 0 0 eng d | ||
022 | _a0172-8172 | ||
024 | 7 |
_a10.1007/BF00270248 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHauzeur, J P | |
245 | 0 | 0 |
_aDouble-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis. _h[electronic resource] |
260 |
_bRheumatology international _c1989 |
||
300 |
_a71-6 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xadverse effects |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAntigens, Bacterial |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
700 | 1 | _aAppelboom, T | |
773 | 0 |
_tRheumatology international _gvol. 9 _gno. 2 _gp. 71-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00270248 _zAvailable from publisher's website |
999 |
_c2688858 _d2688858 |